Two Cases of Psoriasis Responding to Erlotinib: Time to Revisiting Inhibition of Epidermal Growth Factor Receptor in Psoriasis Therapy?
Publisher: Karger
E-ISSN: 1421-9832|225|2|179-182
ISSN: 1018-8665
Source: Dermatology, Vol.225, Iss.2, 2012-10, pp. : 179-182
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract